CSBR Long Call Strategy

CSBR (Champions Oncology, Inc.), in the Healthcare sector, (Biotechnology industry), listed on NASDAQ.

Champions Oncology, Inc. develops and sells technology solutions and products to personalize the development and use of oncology drugs in the United States. Its Tumorgraft Technology Platform is an approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company, through its Tumorgraft Technology Platform, provides personalized cancer care based upon the implantation of human tumors in immune-deficient mice. It also offers Translational Oncology Solutions that utilizes its technology platform to assist pharmaceutical and biotechnology companies with their drug development process. The company provides Lumin Bioinformatics, a software platform and data tool that contains comprehensive information derived from research services and clinical studies, and sold on an annual subscriptions basis. The company markets its products through internet, word of mouth, and sales force to patients and physicians.

CSBR (Champions Oncology, Inc.) trades in the Healthcare sector, specifically Biotechnology, with a market capitalization of approximately $83.6M, a beta of 0.43 versus the broader market, a 52-week range of 5.5-9.63, average daily share volume of 8K, a public-listing history dating back to 2007, approximately 210 full-time employees. These structural characteristics shape how CSBR stock options price implied volatility around earnings windows, capital events, and macro-driven sector rotations.

A beta of 0.43 indicates CSBR has historically moved less than the broader market, dampening realized volatility and producing tighter expected-move bands per unit of dollar exposure.

What is a long call on CSBR?

A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration.

Current CSBR snapshot

As of May 15, 2026, spot at $6.30, ATM IV 337.00%, IV rank 69.63%, expected move 96.61%. The long call on CSBR below is built from the same end-of-day chain, with strikes snapped to listed contracts and premiums pulled from the bid/ask midpoint at a 34-day expiry.

Why this long call structure on CSBR specifically: CSBR IV at 337.00% is mid-range versus its 1-year history, so strategy selection should anchor more to the directional thesis than to the IV regime, with a market-implied 1-standard-deviation move of approximately 96.61% (roughly $6.09 on the underlying). The 34-day window matched to the front-month expiry keeps theta exposure bounded while still capturing the post-snapshot move; longer-dated CSBR expiries trade a higher absolute premium for lower per-day decay. Position sizing on CSBR should anchor to the underlying notional of $6.30 per share and to the trader's directional view on CSBR stock.

CSBR long call setup

The CSBR long call below is built from the end-of-day chain, with each option leg priced at the bid/ask midpoint of its listed strike. With CSBR near $6.30, the first option leg uses a $6.30 strike; additional legs (when the strategy has them) anchor to spot-relative offsets. Premiums come from the bid/ask midpoint on the listed CSBR chain at a 34-day expiry; the cross-strike IV skew is reflected directly in the per-leg values rather than approximated. Quantity sizing assumes one contract per option leg (or 100 CSBR shares for the stock leg in covered calls and collars).

ActionTypeStrike / BasisPremium (est)
Buy 1Call$6.30N/A

CSBR long call risk and reward

Net Premium / Debit
N/A
Max Profit (per contract)
Unbounded
Max Loss (per contract)
Unbounded
Breakeven(s)
None on modeled curve
Risk / Reward Ratio
N/A

Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium.

CSBR long call payoff curve

Modeled P&L at expiration across a range of underlying prices for the long call on CSBR. Each row is one sampled price point from the computed payoff curve; the full curve uses 200 price points internally before being summarized into 10 rows here.

When traders use long call on CSBR

Long calls on CSBR express a bullish thesis with defined risk; traders use them ahead of CSBR catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.

CSBR thesis for this long call

The market-implied 1-standard-deviation range for CSBR extends from approximately $0.21 on the downside to $12.39 on the upside. A CSBR long call expresses a directional view that the underlying closes above the strike plus premium at expiration, ideally with implied volatility holding or expanding to preserve extrinsic value through the hold period. Current CSBR IV rank near 69.63% is mid-range against its 1-year distribution, so the IV signal is neutral; the long call thesis on CSBR should anchor more to the directional view and the expected-move geometry. As a Healthcare name, CSBR options can move on sector-level news flow (peer earnings, regulatory updates, industry-specific macro data) in addition to CSBR-specific events.

CSBR long call positions are structurally bullish; the modeled P&L assumes European-style exercise at expiration and ignores early assignment, transaction costs, dividends paid before expiry on the stock leg (when present), and the bid-ask spread on the listed chain. CSBR positions also carry Healthcare sector concentration risk; news flow inside the sector (peer earnings, regulatory shifts, supply-chain headlines) can move CSBR alongside the broader basket even when CSBR-specific fundamentals are unchanged. Long-premium structures like a long call on CSBR are particularly exposed to IV-crush risk through scheduled events (earnings, FDA decisions, central-bank meetings) where IV typically contracts post-event regardless of the directional outcome. Always rebuild the position from current CSBR chain quotes before placing a trade.

Frequently asked questions

What is a long call on CSBR?
A long call on CSBR is the long call strategy applied to CSBR (stock). The strategy is structurally bullish: A long call buys upside exposure with a fixed maximum loss equal to the premium paid; profit accrues if the underlying closes above the strike plus premium at expiration. With CSBR stock trading near $6.30, the strikes shown on this page are snapped to the nearest listed CSBR chain strike and the premiums come straight from the end-of-day bid/ask midpoint.
How are CSBR long call max profit and max loss calculated?
Max profit is unbounded; max loss equals the premium paid times 100. Breakeven is strike plus premium. For the CSBR long call priced from the end-of-day chain at a 30-day expiry (ATM IV 337.00%), the computed maximum profit is unbounded per contract and the computed maximum loss is unbounded per contract. Live intraday quotes will differ as the chain moves through the trading session.
What is the breakeven for a CSBR long call?
The breakeven for the CSBR long call priced on this page is no defined breakeven on the modeled curve at expiration, derived from end-of-day chain premiums. Breakeven is the underlying price at which the strategy's P&L crosses zero ignoring transaction costs and assignment risk. The current CSBR market-implied 1-standard-deviation expected move is approximately 96.61%; if the move sits well outside the breakeven distance, the structure's risk-reward becomes correspondingly tighter.
When should you consider a long call on CSBR?
Long calls on CSBR express a bullish thesis with defined risk; traders use them ahead of CSBR catalysts (earnings, product launches, macro events) when the expected upside justifies the premium and theta decay.
How does current CSBR implied volatility affect this long call?
CSBR ATM IV is at 337.00% with IV rank near 69.63%, which is mid-range against its 1-year history. Strategy selection depends more on directional thesis and expected move than on a strong IV signal.

Related CSBR analysis